CSPCY Stock Price, Chart, Stats & News
CSPC Pharmaceutical Group Limited (CSPCY) is a dividend-paying stock with a current dividend yield of 3.35% as of Aug 14, 2026. It pays $0.1483 per share over the trailing twelve months and distributes bi-annually. Its dividend has grown at a 24.89% 5-year compound annual rate.
Dividend safety
CSPCY pays out about 195% of earnings, leaving little safety margin.
CSPCY chart
About
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer.
Related lists
Similar securities
Based on sector and market capitalization
